The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker
-
Published:2024-07
Issue:
Volume:Volume 16
Page:329-339
-
ISSN:1179-1314
-
Container-title:Breast Cancer: Targets and Therapy
-
language:en
-
Short-container-title:BCTT
Author:
Buyukbayram MehmetORCID,
Hannarici Zekeriya,
Duzkopru Yakup,
Turhan Aykut,
Caglar Alperen,
Coban Esdur Pınar,
Bilici Mehmet,
Tekin Salim,
Yazılıtaş DoğanORCID
Publisher
Informa UK Limited